Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PARA-CHLOROAMPHETAMINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baumann, MH; Ayestas, MA; Dersch, CM; Rothman, RB
      1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

      NEUROPSYCHOPHARMACOLOGY
    2. O'Loinsigh, ED; Boland, G; Kelly, JP; O'Boyle, KM
      Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    3. Manzana, EJP; Chen, WJA; Champney, TH
      Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels

      BRAIN RESEARCH
    4. Grob, CS
      Deconstructing ecstasy: The politics of MDMA research

      ADDICTION RESEARCH
    5. Rothman, RB; Baumann, MH
      Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

      DRUG DEVELOPMENT RESEARCH
    6. Basura, GJ; Walker, PD
      Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression

      MOLECULAR BRAIN RESEARCH
    7. Ferraro, L; Fuxe, K; Tanganelli, S; Fernandez, M; Rambert, FA; Antonelli, T
      Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil

      NEUROPHARMACOLOGY
    8. Cheetham, SC; Viggers, JA; Slater, NA; Heal, DJ
      Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

      NEUROPHARMACOLOGY
    9. Garcia-Osta, A; Frechilla, D; Del Rio, J
      Effect of p-chloroamphetamine on 5-HT1A and 5-HT7 serotonin receptor expression in rat brain

      JOURNAL OF NEUROCHEMISTRY
    10. Cabrera-Vera, TM; Garcia, F; Pinto, W; Battaglia, G
      Neurochemical changes in brain serotonin neurons in immature and adult offspring prenatally exposed to cocaine

      BRAIN RESEARCH
    11. Ke, M; Mooney, RD; Rhoades, RW
      Increased serotonin in the developing superior colliculus affects receptive-field size of retinotectal afferents but not that of postsynaptic neurons

      VISUAL NEUROSCIENCE
    12. Scorza, C; Silveira, R; Nichols, DE; Reyes-Parada, M
      Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT ofrats. Implications for the development of novel antidepressants with a short onset of action

      NEUROPHARMACOLOGY
    13. Rothman, RB; Ayestas, MA; Dersch, CM; Baumann, MH
      Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates - Implications for primary pulmonary hypertension

      CIRCULATION
    14. Shimizu, I; Adachi, N; Liu, K; Lei, B; Nagaro, T; Arai, T
      Sepsis facilitates brain serotonin activity and impairs learning ability in rats

      BRAIN RESEARCH
    15. KRAMER HK; POBLETE JC; AZMITIA EC
      CHARACTERIZATION OF THE TRANSLOCATION OF PROTEIN-KINASE-C (PKC) BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA ECSTASY) IN SYNAPTOSOMES - EVIDENCE FOR A PRESYNAPTIC LOCALIZATION INVOLVING THE SEROTONIN TRANSPORTER(SERT)/

      Neuropsychopharmacology
    16. UEDA S; AIKAWA M; ISHIZUYAOKA A; KOIBUCHI N; YAMAOKA S; YOSHIMOTO K
      AGE-RELATED DEGENERATION OF THE SEROTONINERGIC FIBERS IN THE ZITTER RAT-BRAIN

      Synapse
    17. BAUMANN MH; AYESTAS MA; ROTHMAN RB
      FUNCTIONAL CONSEQUENCES OF CENTRAL SEROTONIN DEPLETION PRODUCED BY REPEATED FENFLURAMINE ADMINISTRATION IN

      The Journal of neuroscience
    18. DARMANI NA
      COCAINE AND SELECTIVE MONOAMINE UPTAKE BLOCKERS (SERTRALINE, NISOXETINE, AND GBR-12935) PREVENT THE D-FENFLURAMINE-INDUCED HEAD-TWITCH RESPONSE IN MICE

      Pharmacology, biochemistry and behavior
    19. Hamasaki, K; Seta, Y; Yamada, K; Toyoshima, K
      Possible role of serotonin in Merkel-like basal cells of the taste buds ofthe frog, Rana nigromaculata

      JOURNAL OF ANATOMY
    20. HERVAS I; ARTIGAS F
      EFFECT OF FLUOXETINE ON EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN RAT-BRAIN - ROLE OF 5-HT AUTORECEPTORS

      European journal of pharmacology
    21. SOUTHAM E; KIRKBY D; HIGGINS GA; HAGAN RM
      LAMOTRIGINE INHIBITS MONOAMINE UPTAKE IN-VITRO AND MODULATES 5-HYDROXYTRYPTAMINE UPTAKE IN RATS

      European journal of pharmacology
    22. METZGER RR; HANSON GR; GIBB JW; FLECKENSTEIN AE
      3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED ACUTE CHANGES IN DOPAMINE TRANSPORTER FUNCTION

      European journal of pharmacology
    23. ADELL A; ARTIGAS F
      A MICRODIALYSIS STUDY OF THE IN-VIVO RELEASE OF 5-HT IN THE MEDIAN RAPHE NUCLEUS OF THE RAT

      British Journal of Pharmacology
    24. MISANE I; JOHANSSON C; OGREN SO
      ANALYSIS OF THE 5-HT1A RECEPTOR INVOLVEMENT IN PASSIVE-AVOIDANCE IN THE RAT

      British Journal of Pharmacology
    25. BAUMANN MH; ROTHMAN RB
      ALTERATIONS IN SEROTONERGIC RESPONSIVENESS DURING COCAINE WITHDRAWAL IN RATS - SIMILARITIES TO MAJOR DEPRESSION IN HUMANS

      Biological psychiatry
    26. MARONALEWICKA D; NICHOLS DE
      DRUG DISCRIMINATION STUDIES OF THE INTEROCEPTIVE CUES PRODUCED BY SELECTIVE SEROTONIN UPTAKE INHIBITORS AND SELECTIVE SEROTONIN RELEASING AGENTS

      Psychopharmacology
    27. KRAMER HK; POBLETE JC; AZMITIA EC
      ACTIVATION OF PROTEIN-KINASE-C (PKC) BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) OCCURS THROUGH THE STIMULATION OF SEROTONIN RECEPTORS AND TRANSPORTER

      Neuropsychopharmacology
    28. HUETHER G; ZHOU D; RUTHER E
      CAUSES AND CONSEQUENCES OF THE LOSS OF SEROTONERGIC PRESYNAPSES ELICITED BY THE CONSUMPTION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) AND ITS CONGENERS

      Journal of neural transmission
    29. ADELL A; CASANOVAS JM; ARTIGAS F
      COMPARATIVE-STUDY IN THE RAT OF THE ACTIONS OF DIFFERENT TYPES OF STRESS ON THE RELEASE OF 5-HT IN RAPHE NUCLEI AND FOREBRAIN AREAS

      Neuropharmacology
    30. GARTSIDE SE; MCQUADE R; SHARP T
      ACUTE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON 5-HT CELL FIRING AND RELEASE - COMPARISON BETWEEN DORSAL AND MEDIAN RAPHE 5-HTSYSTEMS

      Neuropharmacology
    31. GUNDLAH C; MARTIN KF; HEAL DJ; AUERBACH SB
      IN-VIVO CRITERIA TO DIFFERENTIATE MONOAMINE REUPTAKE INHIBITORS FROM RELEASING AGENTS - SIBUTRAMINE IS A REUPTAKE INHIBITOR

      The Journal of pharmacology and experimental therapeutics
    32. CABRERAVERA TM; GARCIA F; PINTO W; BATTAGLIA G
      EFFECT OF PRENATAL FLUOXETINE (PROZAC) EXPOSURE ON BRAIN-SEROTONIN NEURONS IN PREPUBESCENT AND ADULT MALE-RAT OFFSPRING

      The Journal of pharmacology and experimental therapeutics
    33. CASANOVAS JM; LESOURD M; ARTIGAS F
      THE EFFECT OF THE SELECTIVE 5-HT1A AGONISTS ALNESPIRONE (S-20499) AND8-OH-DPAT ON EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN DIFFERENT REGIONS OF RAT-BRAIN

      British Journal of Pharmacology
    34. JAVED A; VANDEKAR LD; GRAY TS
      P-CHLOROPHENYLALANINE AND FLUOXETINE INHIBIT D-FENFLURAMINE-INDUCED FOS EXPRESSION IN THE PARAVENTRICULAR NUCLEUS, CINGULATE CORTEX AND FRONTAL-CORTEX BUT NOT IN OTHER FOREBRAIN AND BRAIN-STEM REGIONS

      Brain research
    35. FASCIANO J; STEELE T; CASTAGNOLI N; KATZ J; RICAURTE G
      THE EFFECT OF N-METHYLATION ON FENFLURAMINES NEUROTOXIC AND PHARMACOLOGICAL ACTIONS

      Brain research
    36. POLAND RE; LUTCHMANSINGH P; MCCRACKEN JT; ZHAO JP; BRAMMER GL; GROB CS; BOONE KB; PECHNICK RN
      ABNORMAL ACTH AND PROLACTIN RESPONSES TO FENFLURAMINE IN RATS EXPOSEDTO SINGLE AND MULTIPLE DOSES OF MDMA

      Psychopharmacology
    37. MILLER RT; LAU SS; MONKS TJ
      EFFECTS OF INTRACEREBROVENTRICULAR ADMINISTRATION OF 5-(GLUTATHIONE-S-YL)-ALPHA-METHYLDOPAMINE ON BRAIN DOPAMINE, SEROTONIN, AND NOREPINEPHRINE CONCENTRATIONS IN MALE SPRAGUE-DAWLEY RATS

      Chemical research in toxicology
    38. LIN LS; LIN MT
      HYPOTHALAMIC SEROTONIN RELEASE AND RAISED BLOOD-PRESSURE AFTER RAPHE NUCLEI STIMULATION IN RATS

      Brain research bulletin
    39. ANDREWS AM; LADENHEIM B; EPSTEIN CJ; CADET JL; MURPHY DL
      TRANSGENIC MICE WITH HIGH-LEVELS OF SUPEROXIDE-DISMUTASE ACTIVITY AREPROTECTED FROM THE NEUROTOXIC EFFECTS OF 2'-NH2-MPTP ON SEROTONERGIC AND NORADRENERGIC NERVE-TERMINALS

      Molecular pharmacology
    40. SAITO TR; HOKAO R; WAKAFUJI Y; IGARASHI N; AGEMATSU Y; TAKAHASHI KW
      PARA-CHLOROAMPHETAMINE (PCA)-INDUCED EJACULATION IN AGED RATS, SEMEN ANALYSIS AND ARTIFICIAL-INSEMINATION

      Laboratory animals
    41. LI Q; MURAKAMI I; STALL S; LEVY AD; BROWNFIELD MS; NICHOLS DE; VANDEKAR LD
      NEUROENDOCRINE PHARMACOLOGY OF 3 SEROTONIN RELEASERS - 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)BUTANE (MBDB), 5-METHOXY-6-METHYL-2-AMINOINDAN (MMAI) AND P-METHYLTHIOAMPHETAMINE (MTA)

      The Journal of pharmacology and experimental therapeutics
    42. LEW R; SABOL KE; CHOU C; VOSMER GL; RICHARDS J; SEIDEN LS
      METHYLENEDIOXYMETHAMPHETAMINE-INDUCED SEROTONIN DEFICITS ARE FOLLOWEDBY PARTIAL RECOVERY OVER A 52-WEEK PERIOD .2. RADIOLIGAND BINDING ANDAUTORADIOGRAPHY STUDIES

      The Journal of pharmacology and experimental therapeutics
    43. CASANOVAS JM; ARTIGAS F
      DIFFERENTIAL-EFFECTS OF IPSAPIRONE ON 5-HYDROXYTRYPTAMINE RELEASE IN THE DORSAL AND MEDIAN RAPHE NEURONAL PATHWAYS

      Journal of neurochemistry
    44. ZHOU D; HUETHER G; WILTFANG J; HAJAK G; RUTHER E
      SEROTONIN TRANSPORTERS IN THE RAT FRONTAL-CORTEX - LACK OF CIRCADIAN RHYTHMICITY BUT DOWN-REGULATION BY FOOD RESTRICTION

      Journal of neurochemistry
    45. GUDELSKY GA; NASH JF
      CARRIER-MEDIATED RELEASE OF SEROTONIN BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE - IMPLICATIONS FOR SEROTONIN-DOPAMINE INTERACTIONS

      Journal of neurochemistry
    46. SANTUCCI AC; KNOTT PJ; HAROUTUNIAN V
      EXCESSIVE SEROTONIN RELEASE, NOT DEPLETION, LEADS TO MEMORY IMPAIRMENTS IN RATS

      European journal of pharmacology
    47. TAO R; MA ZY; AUERBACH SB
      DIFFERENTIAL REGULATION OF 5-HYDROXYTRYPTAMINE RELEASE BY GABA(A) ANDGABA(B) RECEPTORS IN MIDBRAIN RAPHE NUCLEI AND FOREBRAIN OF RATS

      British Journal of Pharmacology
    48. KEHNE JH; PADICH RA; MCCLOSKEY TC; TAYLOR VL; SCHMIDT CJ
      5-HT MODULATION OF AUDITORY AND VISUAL SENSORIMOTOR GATING .1. EFFECTS OF 5-HT RELEASERS ON SOUND AND LIGHT PREPULSE INHIBITION IN WISTAR RATS

      Psychopharmacology
    49. CAMPBELL DB
      THE USE OF TOXICOKINETICS FOR THE SAFETY ASSESSMENT OF DRUGS ACTING IN THE BRAIN

      Molecular neurobiology
    50. VANDEKAR LD; RITTENHOUSE PA; LI Q; LEVY AD; BROWNFIELD MS
      HYPOTHALAMIC PARAVENTRICULAR, BUT NOT SUPRAOPTIC NEURONS, MEDIATE THESEROTONERGIC STIMULATION OF OXYTOCIN SECRETION

      Brain research bulletin
    51. MCQUADE R; SHARP T
      RELEASE OF CEREBRAL 5-HYDROXYTRYPTAMINE EVOKED BY ELECTRICAL-STIMULATION OF THE DORSAL AND MEDIAN RAPHE NUCLEI - EFFECT OF A NEUROTOXIC AMPHETAMINE

      Neuroscience
    52. KUCZENSKI R; SEGAL DS; CHO AK; MELEGA W
      HIPPOCAMPUS NOREPINEPHRINE, CAUDATE DOPAMINE AND SEROTONIN, AND BEHAVIORAL-RESPONSES TO THE STEREOISOMERS OF AMPHETAMINE AND METHAMPHETAMINE

      The Journal of neuroscience
    53. MAMOUNAS LA; BLUE ME; SIUCIAK JA; ALTAR CA
      BRAIN-DERIVED NEUROTROPHIC FACTOR PROMOTES THE SURVIVAL AND SPROUTINGOF SEROTONERGIC AXONS IN RAT-BRAIN

      The Journal of neuroscience
    54. SERIES HG; LEMASURIER M; GARTSIDE SE; FRANKLIN M; SHARP T
      BEHAVIORAL AND NEUROENDOCRINE RESPONSES TO D-FENFLURAMINE IN RATS TREATED WITH NEUROTOXIC AMPHETAMINES

      JOURNAL OF PSYCHOPHARMACOLOGY
    55. OLDS ME
      DOPAMINE AGONISTS PREVENT OR COUNTERACT THE SUPPRESSION OF BRAIN-STIMULATION REWARD BY FENFLURAMINE

      Pharmacology, biochemistry and behavior
    56. YELLS DP; PRENDERGAST MA; HENDRICKS SE; MILLER ME
      MONOAMINERGIC INFLUENCES ON TEMPORAL PATTERNING OF SEXUAL-BEHAVIOR INMALE-RATS

      Physiology & behavior
    57. RAITERI M; BONANNO G; VALLEBUONA F
      IN-VITRO AND IN-VIVO EFFECTS OF D-FENFLURAMINE - NO APPARENT RELATIONBETWEEN 5-HYDROXYTRYPTAMINE RELEASE AND HYPOPHAGIA

      The Journal of pharmacology and experimental therapeutics
    58. SPRAGUE JE; NICHOLS DE
      THE MONOAMINE OXIDASE-B INHIBITOR L-DEPRENYL PROTECTS AGAINST 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED LIPID-PEROXIDATION AND LONG-TERM SEROTONERGIC DEFICITS

      The Journal of pharmacology and experimental therapeutics
    59. FARFEL GM; SEIDEN LS
      ROLE OF HYPOTHERMIA IN THE MECHANISM OF PROTECTION AGAINST SEROTONERGIC TOXICITY .1. EXPERIMENTS USING 3,4-METHYLENEDIOXYMETHAMPHETAMINE, DIZOCILPINE, CGS-19755 AND NBQX

      The Journal of pharmacology and experimental therapeutics
    60. RIVOT JP; CESPUGLIO R; PUIG S; JOUVET M; BESSON JM
      IN-VIVO ELECTROCHEMICAL MONITORING OF SEROTONIN IN SPINAL DORSAL HORNWITH NAFION-COATED MULTICARBON FIBER ELECTRODES

      Journal of neurochemistry
    61. MARONALEWICKA D; RHEE GS; SPRAGUE JE; NICHOLS DE
      PSYCHOSTIMULANT-LIKE EFFECTS OF P-FLUOROAMPHETAMINE IN THE RAT

      European journal of pharmacology
    62. BAUMANN MH; BECKETTS KM; ROTHMAN RB
      EVIDENCE FOR ALTERATIONS IN PRESYNAPTIC SEROTONERGIC FUNCTION DURING WITHDRAWAL FROM CHRONIC COCAINE IN RATS

      European journal of pharmacology
    63. MORTON KDR; JOHNSON MD; VANDEKAR LD
      SEROTONIN AND STRESS-INDUCED INCREASES IN RENIN SECRETION ARE NOT BLOCKED BY SYMPATHECTOMY ADRENAL MEDULLECTOMY BUT ARE BLOCKED BY BETA-ANTAGONISTS

      Brain research
    64. WICHEMS CH; HOLLINGSWORTH CK; BENNETT BA
      RELEASE OF SEROTONIN-INDUCED BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND OTHER SUBSTITUTED AMPHETAMINES IN CULTURED FETAL RAPHE NEURONS- FURTHER EVIDENCE FOR CALCIUM-INDEPENDENT MECHANISMS OF RELEASE

      Brain research
    65. NOVOTNEY S; LOWY MT
      SHORT-TERM AND LONG-TERM EFFECTS OF P-CHLOROAMPHETAMINE ON HIPPOCAMPAL SEROTONIN AND CORTICOSTEROID RECEPTOR LEVELS

      Brain research
    66. KRAMER HK; POBLETE JCP; AZMITIA EC
      3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) PROMOTES THE TRANSLOCATION OF PROTEIN-KINASE-C (PKC) - REQUIREMENT OF VIABLE SEROTONIN NERVE-TERMINALS

      Brain research
    67. PENEV PD; TUREK FW; ZEE PC
      A SEROTONIN NEUROTOXIN ATTENUATES THE PHASE-SHIFTING EFFECTS OF TRIAZOLAM ON THE CIRCADIAN CLOCK IN HAMSTERS

      Brain research
    68. SABOL KE; RICHARDS JB; LAYTON K; SEIDEN LS
      AMPHETAMINE ANALOGS HAVE DIFFERENTIAL-EFFECTS ON DRL 36-S SCHEDULE PERFORMANCE

      Psychopharmacology
    69. GREEN AR; CROSS AJ; GOODWIN GM
      REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)

      Psychopharmacology
    70. WILSON MA; MOLLIVER ME
      MICROGLIAL RESPONSE TO DEGENERATION OF SEROTONERGIC AXON TERMINALS

      Glia
    71. LEONARDI ETK; AZMITIA EC
      MDMA (ECSTASY) INHIBITION OF MAO TYPE-A AND TYPE-B - COMPARISONS WITHFENFLURAMINE AND FLUOXETINE (PROZAC)

      Neuropsychopharmacology
    72. HENSLER JG; FERRY RC; LABOW DM; KOVACHICH GB; FRAZER A
      QUANTITATIVE AUTORADIOGRAPHY OF THE SEROTONIN TRANSPORTER TO ASSESS THE DISTRIBUTION OF SEROTONERGIC PROJECTIONS FROM THE DORSAL RAPHE NUCLEUS

      Synapse
    73. CHANUT E; BONNET JJ; TROUVIN JH; PLAT M; COSTENTIN J; JACQUOT C
      6-FLUORO-SEROTONIN AS A SUBSTRATE FOR THE NEURONAL SEROTONIN TRANSPORTER

      Journal of neural transmission
    74. MONROE PJ; SMITH DL; WILLIAMS GM; SMITH DJ
      BUFOTENINE HAS A PARACHLOROAMPHETAMINE-LIKE ACTION ON THE STORAGE ANDRELEASE OF SEROTONIN IN RAT SPINAL-CORD SYNAPTOSOMES

      Biogenic amines
    75. HARING JH; FABER KM; WILSON CC
      TRANSIENT REDUCTION IN HIPPOCAMPAL SEROTONERGIC INNERVATION AFTER NEONATAL PARACHLOROAMPHETAMINE TREATMENT

      Developmental brain research
    76. PETTY F; KRAMER G; WILSON L; JORDAN S
      IN-VIVO SEROTONIN RELEASE AND LEARNED HELPLESSNESS

      Psychiatry research
    77. YELLS DP; PRENDERGAST MA; HENDRICKS SE; NAKAMURA M
      FLUOXETINE-INDUCED INHIBITION OF MALE-RAT COPULATORY-BEHAVIOR - MODIFICATION BY LESIONS OF THE NUCLEUS PARAGIGANTOCELLULARIS

      Pharmacology, biochemistry and behavior
    78. VANDEKAR LD; SANZ MCA; YRACHETA JM; KUNIMOTO K; LI QA; LEVY AD; RITTENHOUSE PA
      ICV INJECTION OF THE SEROTONIN 5-HT1B AGONIST CP-93,129 INCREASES THESECRETION OF ACTH, PROLACTIN, AND RENIN AND INCREASES BLOOD-PRESSURE BY NONSEROTONERGIC MECHANISMS

      Pharmacology, biochemistry and behavior
    79. OLDS ME
      OPPOSITE EFFECTS OF PCA AND CHLORIMIPRAMINE ON ICSS AND ON ITS FACILITATION BY AMPHETAMINE

      Pharmacology, biochemistry and behavior
    80. LEVY AD; LI Q; VANDEKAR LD
      REPEATED COCAINE EXPOSURE INHIBITS THE ADRENOCORTICOTROPIC HORMONE RESPONSE TO THE SEROTONIN RELEASER D-FENFLURAMINE AND THE 5-HT1A AGONIST, 8-OH-DPAT

      Neuropharmacology
    81. HESLOP KE; CURZON G
      DEPLETION AND REPLETION OF CORTICAL TISSUE AND DIALYSATE 5-HT AFTER RESERPINE

      Neuropharmacology
    82. RITTENHOUSE PA; BAKKUM EA; LEVY AD; LI Q; YRACHETA JM; KUNIMOTO K; VANDEKAR LD
      CENTRAL STIMULATION OF RENIN SECRETION THROUGH SEROTONERGIC, NONCARDIOVASCULAR MECHANISMS

      Neuroendocrinology
    83. RITTENHOUSE PA; BAKKUM EA; LEVY AD; LI Q; CARNES M; VANDEKAR LD
      EVIDENCE THAT ACTH-SECRETION IS REGULATED BY SEROTONIN(2A 2C) (5-HT2A/2C) RECEPTORS/

      The Journal of pharmacology and experimental therapeutics
    84. BROENING HW; BACON L; SLIKKER W
      AGE MODULATES THE LONG-TERM BUT NOT THE ACUTE EFFECTS OF THE SEROTONERGIC NEUROTOXICANT 3,4-METHYLENEDIOXYMETHAMPHETAMINE

      The Journal of pharmacology and experimental therapeutics
    85. SERIES HG; MOLLIVER ME
      IMMUNOCYTOCHEMICAL EVIDENCE FOR SEROTONERGIC NEUROTOXICITY OF N-ETHYL-METHYLENEDIOXYAMPHETAMINE (MDE)

      Experimental neurology
    86. MATSUNO K; SENDA T; MATSUNAGA K; MITA S
      AMELIORATING EFFECTS OF A RECEPTOR LIGANDS ON THE IMPAIRMENT OF PASSIVE-AVOIDANCE TASKS IN MICE - INVOLVEMENT IN THE CENTRAL ACETYLCHOLINERGIC SYSTEM

      European journal of pharmacology
    87. COLADO MI; ORMAZABAL MJ; GOICOECHEA C; LOPEZ F; ALFARO MJ; MARTIN MI
      INVOLVEMENT OF CENTRAL SEROTONERGIC PATHWAYS IN ANALGESIA ELICITED BYSALMON-CALCITONIN IN THE MOUSE

      European journal of pharmacology
    88. COLADO MJ; GREEN AR
      A STUDY OF THE MECHANISM OF MDMA (ECSTASY)-INDUCED NEUROTOXICITY OF 5-HT NEURONS USING CHLORMETHIAZOLE, DIZOCILPINE AND OTHER PROTECTIVE COMPOUNDS

      British Journal of Pharmacology
    89. LUTHMAN J; HERRERAMARSCHITZ M; LINDQVIST E
      UNILATERAL NEONATAL INTRACEREBROVENTRICULAR 6-HYDROXYDOPAMINE ADMINISTRATION IN RATS .1. EFFECTS ON SPONTANEOUS AND DRUG-INDUCED ROTATIONALBEHAVIOR AND ON POSTMORTEM MONOAMINE LEVELS

      Psychopharmacology
    90. JONES DNC; HOLTZMAN SG
      INFLUENCE OF NALOXONE UPON MOTOR-ACTIVITY INDUCED BY PSYCHOMOTOR STIMULANT-DRUGS

      Psychopharmacology
    91. JAKALA P; MAZURKIEWICZ M; SIRVIO J; RIEKKINEN P; RIEKKINEN P
      THE BEHAVIORAL-EFFECTS OF SEROTONIN SYNTHESIS INHIBITION AND QUISQUALIC ACID-INDUCED LESIONS OF THE NUCLEUS BASALIS MAGNOCELLULARIS IN RATS

      General pharmacology
    92. BRODKIN J; MALYALA A; NASH JF
      EFFECT OF ACUTE MONOAMINE DEPLETION ON 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED NEUROTOXICITY

      Pharmacology, biochemistry and behavior
    93. PERGOLA PE; SVED AF; VOOGT JL; ALPER RH
      EFFECT OF SEROTONIN ON VASOPRESSIN RELEASE - A COMPARISON TO CORTICOSTERONE, PROLACTIN AND RENIN

      Neuroendocrinology
    94. CELADA P; ARTIGAS F
      MONOAMINE-OXIDASE INHIBITORS INCREASE PREFERENTIALLY EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN THE MIDBRAIN RAPHE NUCLEI - A BRAIN MICRODIALYSISSTUDY IN THE AWAKE RAT

      Naunyn-Schmiedeberg's archives of pharmacology
    95. RICHARDS JB; SABOL KE; SEIDEN LS
      FLUOXETINE PREVENTS THE DISRUPTIVE EFFECTS OF FENFLURAMINE ON DIFFERENTIAL-REINFORCEMENT-OF-LOW-RATE 72 2ND SCHEDULE PERFORMANCE

      The Journal of pharmacology and experimental therapeutics
    96. ELAYAN I; GIBB JW; HANSON GR; LIM HK; FOLTZ RL; JOHNSON M
      SHORT-TERM EFFECTS OF 2,4,5-TRIHYDROXYAMPHETAMINE, 2,4,5-TRIHYDROXYMETHAMPHETAMINE AND 3,4-DIHYDROXYMETHAMPHETAMINE ON CENTRAL TRYPTOPHAN-HYDROXYLASE ACTIVITY

      The Journal of pharmacology and experimental therapeutics
    97. JOHNSON MD; MA PM
      LOCALIZATION OF NADPH DIAPHORASE ACTIVITY IN MONOAMINERGIC NEURONS OFTHE RAT-BRAIN

      Journal of comparative neurology
    98. LEVY AD; RITTENHOUSE PA; BONADONNA AM; SANZ MCA; BETHEA CL; VANDEKAR LD
      REPEATED EXPOSURE TO COCAINE PRODUCES LONG-LASTING DEFICITS IN THE SEROTONERGIC STIMULATION OF PROLACTIN AND RENIN, BUT NOT ADRENOCORTICOTROPIN SECRETION

      European journal of pharmacology
    99. HARVEY JA; MCMASTER SE; ROMANO AG
      METHYLENEDIOXYAMPHETAMINE - NEUROTOXIC EFFECTS ON SEROTONERGIC PROJECTIONS TO BRAIN-STEM NUCLEI IN THE RAT

      Brain research
    100. PAVONE F; FAGIOLI S; CASTELLANO C
      EFFECTS OF OXOTREMORINE ON INHIBITORY AVOIDANCE-BEHAVIOR IN 2 INBRED STRAINS OF MICE - INTERACTION WITH 5-METHOXY-NN-DIMETHYLTRIPTAMINE

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:27:33